OptiNose, Inc.

OptiNose, Inc. price (OPTN)

$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
High
Low
Prev. Close

About OptiNose, Inc.

OptiNose, Inc. is a pharmaceutical company, which engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in May 2010 and is headquartered in Yardley, PA.

Sector
Health Services
CEO
Peter K. Miller
Industry
Health Care
Exchange
NAS

Top Stories

Coming soon.